Barron's Recap: 16 All-Star Women Financial Advisors

  • The cover story in this weekend's Barron's is a look at the biggest battle in biotechnology.
  • This issue also includes a special report on 16 all-star women advisors and a look at companies that could double earnings.
  • The prospects for Whirlpool, Procter & Gamble, Express Scripts, Medical Properties Trust and more are covered in feature stories as well.

Cover Story

"Biotech's Biggest Battle" by Andrew Bary.

Thousands of lives -- and potentially billions of dollars -- are at stake, according to this week's cover story in Barron's. In the biggest battle in biotechnology right now, Sarepta Therapeutics Inc SRPT is up big due to a skeptical FDA report on a muscular dystrophy drug from rival BioMarin Pharmaceutical Inc. BMRN. See why Barron's thinks Sarepta could double if its competing drug is approved in February.

See also: 7 Stocks Institutional Investors Bought Like Crazy In Q3

Feature Stories

In "Whirlpool Enters Up Cycle," Avi Salzman makes the case that even though Whirlpool Corporation WHR was dinged by a strong dollar, smart acquisitions and cost cutting will help boost its shares by up to 25 percent.

"It's Time for Procter & Gamble to Split" by Leslie P. Norton points out that the transformation at Procter & Gamble Co PG has yet to pay off for shareholders. Could a breakup be the best option at this point?

Steve Garmhausen's "Women Financial Advisors: 16 All-Stars" features a roster of financial pros who have made the Barron's list of Top 100 Women Advisors for 10 years in a row. Of course, their advice today is as solid as ever.

The first eight of the all-stars from the Barron's list of Top 100 Women Advisors are presented in "All-Star Women: Attkiss, Bach, Bell, Brede, Cooley, Crockett, Deatherage, Hatchett" by Steve Garmhausen. See who was a one-time Olympic hopeful and which one became an advisor by accident.

In Steve Garmhausen's " All-Star Women: Haussmann, Hewitt, Jorgensen, Kaplan, Oberlander, Raihle, Sager, Salomon," the remainder of the 16 all-star advisors are profiled. Find out which proud contrarian smells opportunity now and who got her start in textiles.

"The Whole Story at Express Scripts" by Bill Alpert indicates that amid allegations about huge markups, pharmacy-benefit manager Express Scripts Holding Company ESRX has been praised for its patient discounts.

In a bear market for natural resources, the T. Rowe Price New Era fund, led by Shawn Driscoll, is reducing risk and outperforming its peers, says Crystal Kim's "Playing a Bad Hand." If Driscoll is right, commodities investors could experience a déjà vu of the 1981 downturn.

Check out "Four Companies That Could Double Earnings," in which Jack Hough makes a case that shares of Alphabet Inc GOOGL and others could rise as much as 20 percent over the next year as investors focus on the companies' stellar growth prospects.

In "Get Ready for a Shaky EU and Higher Oil, Dollar, and Gold," by Leslie P. Norton interviews Larry Jeddeloh of the Institutional Strategist. In the article, Jeddeloh looks at the Mideast, the European Union and how a rising dollar is creating new realities for investors.

David Englander's "A Hospital REIT on the Mend" discusses how Medical Properties Trust, Inc. MPW has been on an acquisition binge. To pay down its debt level, the real estate investment trust (REIT) will look to sell assets, which should lift its shares.

"Going to Mars on a New Mayflower" is an editorial commentary by Thomas G. Donlan in which he discusses how exploration is only the start of a long voyage.

In Barron's Asia: "Clock Ticks for Aquino to Secure Lasting Legacy" by William Pesek says that Aquino is no longer the sick man of Asia. Here are four ways to ensure the revival of the Philippines is more than skin deep.

See also: Millennials And Black Friday: Is There A Misunderstanding?

Columns

Columns in this weekend's Barron's discuss:

  • The hidden message of the Federal Reserve minutes
  • What impact terrorists have on stock market fundamentals
  • How the Square IPO has stirred up the mobile payments business
  • Venture capital for the little guy
  • The profit and the perils of fund distributions
  • How the ETF fee wars have ramped up
  • How the strong dollar shrinks value of foreign firms' payouts
  • Whether inflation is likely to jump by January

At the time of this writing, the author had no position in the mentioned equities.

Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.

Posted In: REITBarron'sMarketsMediaGeneralAlphabetBioMarin Pharmaceuticalexpress scriptsGooglemedical properties trustprocter & gambleSarepta TherapeuticsWhirlpool
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...